Target intelligence / Profile preview

NSG2 antisense RNA 1 (NSG2-AS1)

Target: NSG2-AS1
Molecular classification: Long non-coding RNA (lncRNA), Antisense RNA

Overview

NSG2 antisense RNA 1 (NSG2-AS1) is a long non-coding RNA (lncRNA) gene located in the human genome. It is transcribed antisense to the NSG2 (Neuron-Specific Gene 2) locus. As an antisense RNA, its sequence runs opposite to the NSG2 protein-coding gene, but its biological function has not been characterized in peer-reviewed research. There is currently no evidence for direct protein-coding function, involvement in signal transduction, enzymatic activity, or established utility as a therapeutic target or clinical biomarker.

Other names: LOC102724551

Biological functions

Other (function currently uncharacterized in the literature)

Beyond the preview

Go deeper on NSG2 antisense RNA 1 (NSG2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NSG2 antisense RNA 1 (NSG2-AS1).

Explore the full profile